147 related articles for article (PubMed ID: 22450559)
1. Ocular findings in human immunodeficiency virus patients in Washington, DC.
Kaleem MA; Ramsahai S; Del Fierro K; Rasul S; Onumah C; Lerebours V; Gajjala J; Copeland RA; Jones LS
Int Ophthalmol; 2012 Apr; 32(2):145-51. PubMed ID: 22450559
[TBL] [Abstract][Full Text] [Related]
2. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in Central South China.
Luo J; Jing D; Kozak I; Huiming Z; Siying C; Yezhen Y; Xin Q; Luosheng T; Adelman RA; Forster SH
Ophthalmic Epidemiol; 2013 Jun; 20(3):170-5. PubMed ID: 23713918
[TBL] [Abstract][Full Text] [Related]
4. Ocular Manifestations in Patients with Human Immunodeficiency Virus Infection in the Pre-HAART Versus the HAART Era in the North Indian Population.
Agarwal A; Singh R; Sharma A; Gupta V; Dogra MR
Ocul Immunol Inflamm; 2017 Jun; 25(3):396-404. PubMed ID: 26910292
[TBL] [Abstract][Full Text] [Related]
5. Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus / acquired immune deficiency syndrome.
Venkatesh KK; Biswas J; Kumarasamy N
Indian J Ophthalmol; 2008; 56(5):391-3. PubMed ID: 18711267
[TBL] [Abstract][Full Text] [Related]
6. Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era.
Lai TY; Wong RL; Luk FO; Chow VW; Chan CK; Lam DS
Clin Exp Ophthalmol; 2011 Mar; 39(2):99-104. PubMed ID: 20796263
[TBL] [Abstract][Full Text] [Related]
7. Anterior segment and external ocular disorders associated with HIV infections in the era of HAART in Chiang Mai University Hospital, a prospective descriptive cross sectional study.
Singalavanija T; Ausayakhun S; Tangmonkongvoragul C
PLoS One; 2018; 13(2):e0193161. PubMed ID: 29466424
[TBL] [Abstract][Full Text] [Related]
8. Ocular complications of human immunodeficiency virus infection in eastern china.
Wang Z; Jia R; Ge S; He T; Zhang Y; Yang Y; Wang Y; Shi W; Ji Y; Ye F; Chen P; Lu J; Sun J; Xu X; Zhou Y; Gu P; Luo M; Lu H; Fan X
Am J Ophthalmol; 2012 Feb; 153(2):363-369.e1. PubMed ID: 21982101
[TBL] [Abstract][Full Text] [Related]
9. HIV-associated retinopathy in the HAART era.
Goldberg DE; Smithen LM; Angelilli A; Freeman WR
Retina; 2005; 25(5):633-49; quiz 682-3. PubMed ID: 16077362
[TBL] [Abstract][Full Text] [Related]
10. The Changing Global Epidemic of HIV and Ocular Disease.
Peters RPH; Kestelyn PG; Zierhut M; Kempen JH
Ocul Immunol Inflamm; 2020 Oct; 28(7):1007-1014. PubMed ID: 32396027
[No Abstract] [Full Text] [Related]
11. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.
Shah SU; Kerkar SP; Pazare AR
Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644
[TBL] [Abstract][Full Text] [Related]
12. Ocular manifestation of HIV/AIDS and correlation with CD4+ cells count among adult HIV/AIDS patients in Jimma town, Ethiopia: a cross sectional study.
Bekele S; Gelaw Y; Tessema F
BMC Ophthalmol; 2013 May; 13():20. PubMed ID: 23710936
[TBL] [Abstract][Full Text] [Related]
13. Ocular manifestations of HIV infection.
Jabs DA
Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
[TBL] [Abstract][Full Text] [Related]
14. [Ocular manifestations of children living with HIV/AIDS in Kinshasa].
Nsiangani NL; Kaimbo Wa Kaimbo D; Kapepela MK
Bull Soc Belge Ophtalmol; 2013; (322):117-24. PubMed ID: 24923092
[TBL] [Abstract][Full Text] [Related]
15. Ocular findings in acquired immunodeficiency syndrome patients in Lagos, Nigeria.
Onakoya AO; Odeyemi MG; Aribaba OT; Akinsola FB
Nig Q J Hosp Med; 2012; 22(1):52-7. PubMed ID: 23175881
[TBL] [Abstract][Full Text] [Related]
16. Medical management of human immunodeficiency virus infection.
Kempen JH
Indian J Ophthalmol; 2008; 56(5):385-90. PubMed ID: 18711266
[TBL] [Abstract][Full Text] [Related]
17. Intestinal parasitic infections and its association with undernutrition and CD4 T cell levels among HIV/AIDS patients on HAART in Butajira, Ethiopia.
Gedle D; Kumera G; Eshete T; Ketema K; Adugna H; Feyera F
J Health Popul Nutr; 2017 May; 36(1):15. PubMed ID: 28506307
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment.
Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
Ophthalmology; 2007 Apr; 114(4):780-6. PubMed ID: 17258320
[TBL] [Abstract][Full Text] [Related]
19. Incidence Rate and Risk Factors for Contralateral Eye Involvement among Patients with AIDS and Cytomegalovirus Retinitis Treated with Local Therapy.
Sittivarakul W; Benjhawaleemas T; Aui-Aree N; Jirarattanasopa P; Liabsuetrakul T
Ocul Immunol Inflamm; 2016 Oct; 24(5):530-6. PubMed ID: 26327465
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
